Table 2.
Disease | Inheritance | Gene | Bleeding Diathesis |
---|---|---|---|
Arthrogryposis, renal dysfunction and cholestasis | AR |
VPS33B
VIPAS39 |
Severe |
CalDAG-GEFI related platelet disorder | AR | RASGRP2 | Moderate-severe |
Cediak-Higashi Syndrome | AR | CHS1 | Moderate-severe |
Combined alpha-delta granule deficiency | AR/AD | Unknown | Mild-moderate |
COX-1 deficiency | AR/AD | PTGSA | Moderate-severe |
Delta granule deficiency | AR/AD | Unknown | Mild-moderate |
Glanzmann thrombasthenia | AR | ITGA2B, ITGB3 | Moderate-severe |
Glycoprotein IV (GPIV) deficiency | AR | GP4 | Mild |
Glycoprotein VI (GPVI) deficiency | AR | GP6 | Mild |
Gs platelet defect | AD (if paternally inherited) | GNAS | Mild |
Hermansky–Pudlak syndrome | AR | HPS1, ADTB3A, HPS3, HPS4, HPS5, HPS6, DTNBP1, BLOC1S3, AP3D1, BLOC1S6 | Moderate-severe |
Leukocyte adhesion deficiency, type III | AR | FERMT3 | Moderate-severe |
P2Y12 deficiency | AR | P2RY12 | Moderate-severe |
Phospholipase A2 (cPLA2) deficiency | not determined | PLA2G4A | Moderate-severe |
PKCδ deficiency | AR | PRKCD | Absent |
Primary secretion defect | AR/AD | Unknown | Mild-moderate |
Quebec platelet disorder | AD | PLAU | Moderate-severe |
Scott syndrome | AR | TMEM16F | Mild-moderate |
Thromboxane A2 receptor defect | AD | TBXA2R | Mild |
Tx synthase deficiency | AD/AR | TBXAS1 | Moderate |